Evaluating Social Connectedness to Support Recovery from Opioid Use Disorder during the Postpartum Period
评估社会联系以支持产后阿片类药物使用障碍的恢复
基本信息
- 批准号:10681764
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic achievementAnxietyBehavioralBirthBuffersChildChildbirthControl GroupsDataData AnalyticsDevelopmentEcological momentary assessmentElementsEmotionalEvidence based treatmentFamilyGeneral PopulationGenerationsGoalsHealthIndividualInfantInterventionInterviewKnowledgeLonelinessMachine LearningMaternal MortalityMedical RecordsMental DepressionMothersMotivationOpioidOutcomeOverdosePainPain managementParticipantPatternPerinatalPlayPopulationPostpartum DepressionPostpartum PeriodPregnancyPrevalencePreventionRecoveryRecovery SupportRelapseResearch Project GrantsRiskRisk FactorsRoleSamplingSignal TransductionSleep disturbancesSocial isolationSocial outcomeSocial supportSpecialistStressSubstance Use DisorderTarget PopulationsTestingTheoretical modelTimeWomanWorkcare giving burdencaregivingcravingfoster carefourth trimesterhigh riskillicit opioidimprovedindividualized medicineinfant outcomeinformantnovelopioid misuseopioid overdoseopioid useopioid use disorderoverdose deathpeer supportperinatal periodpreventrelapse preventionrelapse risksocialsocial attachmentstatisticsstress managementstressor
项目摘要
PROJECT SUMMARY
The prevalence of opioid use disorder (OUD) during pregnancy has increased by nearly 500% over the past 15
years. While motivation for and compliance with OUD treatment during pregnancy is heightened, up to 80% of
postpartum individuals with OUD relapse to illicit opioid use within six months of childbirth. A growing body of
evidence indicates that, in the general population, positive social connectedness and strong social bonds are
associated with improved OUD recovery outcomes (e.g., reduced craving, lower risk of relapse). Conversely,
loneliness and social isolation are significant predictors of opioid misuse and relapse, particularly for women.
Loneliness increases during transitional periods including from pregnancy to postpartum, signaling increased
risk for adverse recovery outcomes. Moreover, relapse risk during the fourth trimester (i.e., the time from delivery
to postpartum week 12) may be compounded by unique postpartum stressors, including postpartum depression
and anxiety, sleep disturbances, heightened need for pain management, and caregiving-specific stress. Our
overall goal is to understand the role of social connectedness in OUD-related recovery outcomes, specifically
during the postpartum fourth trimester, an ideal inflection point with untapped potential. To achieve this goal we
will pursue three aims. The first two aims will utilize existing data (derived from DP2-HD105541; PI: Allen) from
50 participants with OUD and 25 control participants who were followed from pregnancy through five months
postpartum. Using ecological momentary assessments (EMA) paired with medical record data, we will assess
social connectedness and OUD-related recovery outcomes. We will evaluate differing theoretical models of
social connectedness in this population by testing the main and stress-buffering effects of social connectedness
on recovery outcomes up to one year postpartum (Aim 1). Additionally, we will characterize dynamic changes in
social connectedness across the fourth trimester and how patterns/changes relate to mothers’ recovery
outcomes (Aim 2). Lastly, we will complete key informant interviews with 30 participants from the target
population to explore the feasibility, acceptability, and opportunities for intervention to enhance social
connectedness to improve the treatment of OUD and prevent postpartum relapse (Aim 3). The results of this
study, regardless of outcome, will directly contribute to scientific knowledge on the role of social connectedness
in postpartum OUD recovery. Moreover, this work will allow for the identification of new intervention targets,
which will contribute to the development of novel, high-impact relapse prevention treatments tailored to the fourth
trimester, a unique inflection point with ample untapped opportunity. This will be directly impactful to the 80,000-
120,000 women, infants, and families suffer the consequences of perinatal OUD every year.
项目摘要
在过去的15年中,妊娠期间阿片类药物使用障碍(OUD)的患病率增加了近500%。
年虽然怀孕期间接受OUD治疗的动机和依从性提高,但高达80%的
产后OUD患者在分娩6个月内复发非法阿片类药物使用。越来越多的
有证据表明,在一般人群中,积极的社会联系和强大的社会纽带是
与改善的OUD恢复结果相关(例如,减少渴望,降低复发风险)。相反地,
孤独和社会孤立是阿片类药物滥用和复吸的重要预测因素,特别是对妇女而言。
在过渡期(包括从怀孕到产后),信号传导增加,
不利恢复结果的风险。此外,在第四个三个月期间复发的风险(即,交货后的时间
到产后第12周)可能会受到独特的产后压力因素的影响,包括产后抑郁症
以及焦虑、睡眠障碍、对疼痛管理的高度需求和特定于工作的压力。我们
总体目标是了解社会联系在OUD相关恢复结果中的作用,特别是
在产后的第四个三个月,一个理想的转折点与未开发的潜力。为了实现这一目标,
我们将追求三个目标。前两个目标将利用现有数据(来自DP 2-HD 105541; PI:艾伦),
50名OUD参与者和25名对照参与者从怀孕到5个月进行随访
产后使用生态瞬时评估(EMA)与医疗记录数据配对,我们将评估
社会联系和OUD相关的恢复结果。我们将评估不同的理论模型,
通过测试社会联系的主要作用和压力缓冲作用,
产后一年内的恢复结果(目标1)。此外,我们将描述动态变化,
第四个三个月的社会联系以及模式/变化与母亲恢复的关系
(目标2)。最后,我们将与目标公司的30名参与者进行关键线人访谈
探讨干预的可行性、可接受性和机会,
连通性,以改善OUD的治疗和预防产后复发(目标3)。的结果
研究,无论结果如何,将直接有助于科学知识的作用,社会联系
产后OUD恢复。此外,这项工作将有助于确定新的干预目标,
这将有助于开发新的,高影响力的复发预防治疗,
三个月,一个独特的转折点,有大量的未开发的机会。这将直接影响到80000-
每年有120,000名妇女、婴儿和家庭遭受围产期OUD的后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alicia M Allen其他文献
Alicia M Allen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alicia M Allen', 18)}}的其他基金
Hormonal Response to Infant Caregiving: A Novel Strategy to Break the Opioid Relapse Cycle during the Postpartum Period
婴儿护理的荷尔蒙反应:打破产后阿片类药物复发周期的新策略
- 批准号:
10001201 - 财政年份:2020
- 资助金额:
$ 23.03万 - 项目类别:
Testing the Feasibility of a Novel Smoking Cessation Intervention by Timing Quit Dates to Menstrual Phase in a Quitline Setting
通过在戒烟热线设置中将戒烟日期安排在月经期来测试新型戒烟干预措施的可行性
- 批准号:
9926433 - 财政年份:2018
- 资助金额:
$ 23.03万 - 项目类别:
Allopregnanolone in Short-Term Smoking Abstinence
四氢孕酮在短期戒烟中的应用
- 批准号:
8216292 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
相似海外基金
A Randomized Controlled Trial of Cognitive Behavioral Therapy via Videoconference for Anxiety in Children and Adolescents
通过视频会议进行认知行为疗法治疗儿童和青少年焦虑的随机对照试验
- 批准号:
23K02949 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Behavioral telehealth in low-resource primary care settings for anxiety and depression in youth: A randomized effectiveness-implementation study
资源匮乏的初级保健机构中针对青少年焦虑和抑郁的行为远程医疗:一项随机有效性实施研究
- 批准号:
10731716 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Adaptation and implementation of a behavioral mHealth intervention to reduce anxiety and depression and end the HIV epidemic in the rural South
适应和实施行为移动健康干预措施,以减少焦虑和抑郁并结束南方农村地区的艾滋病毒流行
- 批准号:
10619925 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Development of an Individualized Cognitive Behavioral Therapy Program for Depression and Anxiety in Older Adults
开发针对老年人抑郁和焦虑的个体化认知行为治疗方案
- 批准号:
22K03175 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10355810 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Feasibility, Preliminary Effectiveness, and Sustainability of a Cognitive-Behavioral Therapy Program Tailored for Youth with Autism and Anxiety Treated in Real-World Community-Based Clinics
为患有自闭症和焦虑症的青少年量身定制的认知行为治疗计划的可行性、初步有效性和可持续性,并在现实世界的社区诊所进行治疗
- 批准号:
10542409 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
An Empirical Study of Cognitive Behavioral Therapy Approaching Anxiety and Related Autism Spectrum Disorder Traits
认知行为疗法治疗焦虑及相关自闭症谱系障碍特征的实证研究
- 批准号:
22H01089 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Feasibility, Preliminary Effectiveness, and Sustainability of a Cognitive-Behavioral Therapy Program Tailored for Youth with Autism and Anxiety Treated in Real-World Community-Based Clinics
为患有自闭症和焦虑症的青少年量身定制的认知行为治疗计划的可行性、初步有效性和可持续性,并在现实世界的社区诊所进行治疗
- 批准号:
10355838 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:














{{item.name}}会员




